UNICREDIT BANK/CALL/FRESENIUS/28/1/19.03.25 Share Price

Warrant

DE000HD4VY88

Real-time BOERSE MUENCHEN 11:31:29 04/07/2024 am IST
3.07 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/FRESENIUS/28/1/19.03.25
Current month+4.42%
1 month-19.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
04/24/04 3.07 0.00%
03/24/03 3.07 +1.99%
02/24/02 3.01 -2.27%
01/24/01 3.08 +4.76%
28/24/28 2.94 +1.73%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 11:31 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FRESENIUS SE & CO. KGAA
IssuerLogo Issuer UniCredit UniCredit
WKN HD4VY8
ISINDE000HD4VY88
Date issued 22/04/2024
Strike 28
Maturity 19/03/2025 (259 Days)
Parity 1 : 1
Emission price 2.94
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 4.85
Lowest since issue 2.83
Delta0.62x
Omega 5.679
Premium9.26x
Gearing9.2x
Moneyness 1.016
Difference Strike -0.695
Difference Strike %-2.48%
Spread 0.05
Spread %1.60%
Theoretical value 3.095
Implied Volatility 26.48 %
Total Loss Probability 46.97 %
Intrinsic value 0.4600
Present value 2.635
Break even 31.10 €
Theta-0.04x
Vega0.09x
Rho0.1x

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.46 EUR
Average target price
37.26 EUR
Spread / Average Target
+30.91%
Consensus